Autoimmune diseases are more common in women partly because they have two X chromosomes, which contain many immune-related genes, and because women tend to have stronger immune responses that can sometimes mistakenly attack the body’s own tissues.
FIND YOUR EVERYDAY STACK | SHOP SUPPLEMENTS
Science-backed tools designed to improve your healthspan and longevity.
Across most countries, women live longer than men. In the United States and globally, female life expectancy consistently exceeds male life expectancy by several years. This gender gap has been observed for decades — and not just in humans, but across many species.
But here’s where the story becomes more nuanced.
While women tend to have a longer average lifespan, they also spend more years living with chronic disease, autoimmune conditions, and functional decline. In other words, women often outlive men — but not necessarily in better health.
This tension is known as the female longevity paradox. To understand it, we need to look at biology, behavior, and how aging unfolds across the lifespan.
Researchers have long been intrigued by the consistent difference in life expectancy between men versus women. Several factors help explain why women live longer than men on average.
From birth, survival patterns diverge. Newborn girls tend to have lower infant mortality and neonatal mortality compared to newborn boys. This phenomenon — sometimes referred to as excess male infant mortality — appears across many populations.
Biologically, male infants are more vulnerable to certain respiratory complications, premature birth outcomes, and developmental stressors. These early survival differences contribute to the overall gap in life expectancy.
As children grow into adolescence and adulthood, mortality patterns shift further. Young men experience higher death rates from life-threatening injuries, violence, and certain risky behaviors.
On average, men tend to engage more frequently in behaviors associated with higher risk — including dangerous driving, certain forms of drug use, and higher rates of fatal accidents. These patterns significantly influence how many deaths occur in younger age groups and widen the sex gap in survival.
Over time, men also show higher mortality from several major causes of death, including certain cardiovascular diseases and liver cirrhosis. Historically, smoking and occupational exposures have contributed to higher male death rates in many countries.
Together, these early-life, behavioral, and disease-related factors help explain why women outlive men and maintain a higher life expectancy across most countries.
But that’s only half the picture.
Life expectancy tells us how long people live. Healthspan tells us how long they live in good health.
Women often have a longer life expectancy — but they are also more likely to live with chronic conditions, disability, and autoimmune disease for a longer period of time. This creates a gap between living longer and living well.
Understanding that gap requires looking more closely at immune biology and hormones.
Women account for the majority of autoimmune diseases worldwide. Conditions like lupus, rheumatoid arthritis, and multiple sclerosis disproportionately affect females.
Why?
One reason may lie in genetics. Women have two X chromosomes, while men have one X and one Y chromosome. The X chromosome contains many genes involved in immune regulation. Managing gene expression across two X chromosomes requires complex cellular control — and subtle disruptions may increase autoimmune risk.
At the same time, women often demonstrate stronger immune responses compared to male counterparts. This may provide advantages in fighting infectious diseases and improving survival earlier in life. But a more reactive immune system may also increase the likelihood of immune misfiring — where the body mistakenly attacks its own tissues.
In this sense, the female advantage in survival may come with tradeoffs.
Sex differences in longevity are also shaped by hormones.
Estrogen plays an important role in cardiovascular function, inflammation regulation, and metabolic health. Before menopause, women tend to have lower rates of heart disease compared to men. However, this protection shifts during the menopause transition, when estrogen levels decline.
After midlife, the risk of cardiovascular diseases rises, and women may experience changes in insulin sensitivity, body composition, sleep patterns, and inflammatory signaling. These shifts can increase vulnerability to chronic disease — even as overall life expectancy remains higher.
Hormonal transitions do not negate women’s longer survival, but they do help explain why many women experience increased health challenges in later decades.
Longevity is not determined by chromosomes alone. Lifestyle, stress, environmental exposures, and access to medical care all influence how aging unfolds.
Epigenetics — the chemical regulation of gene activity — provides a bridge between biology and lived experience. Hormonal changes, chronic stress, smoking, diet, and sleep patterns can all shape epigenetic markers associated with biological aging.
This means the female longevity paradox is not simply about sex differences. It reflects an interaction between genetic architecture, immune resilience, hormones, and environmental factors accumulated over time.
In summary:
Women have early-life survival advantages.
Men tend to experience higher mortality from injuries and certain diseases.
Women demonstrate strong immune resilience — but face higher rates of autoimmune diseases.
Hormonal transitions reshape cardiovascular and metabolic risk in midlife.
Environmental and behavioral factors further influence biological aging.
The result is a consistent pattern: women live longer than men on average, but may spend more years managing chronic disease.
The female longevity paradox highlights an important shift in focus. The goal is not simply longer life — it is longer healthspan.
For women, this means:
Prioritizing cardiovascular health well before menopause
Building and maintaining muscle mass and bone density to support metabolic resilience and musculoskeletal health
Monitoring inflammatory markers and autoimmune symptoms
Protecting sleep and stress recovery
Advocating for proactive, evidence-based medical care
Longer life expectancy is an advantage. The next step is ensuring those extra years are strong, functional, and vibrant.
Understanding the biology behind why women live longer than men is not just a research question — it’s a roadmap for smarter prevention and personalized longevity strategies.
And that’s where modern health science is headed.
Women live longer than men due to a combination of early-life survival advantages, lower mortality from injuries in young adulthood, and differences in disease patterns such as higher male mortality from cardiovascular disease and other conditions.
The female longevity paradox refers to the pattern where women live longer than men on average but spend more years living with chronic diseases, autoimmune conditions, and disability.
Autoimmune diseases are more common in women partly because they have two X chromosomes, which contain many immune-related genes, and because women tend to have stronger immune responses that can sometimes mistakenly attack the body’s own tissues.
Hägg and Jylhävä. Sex differences in biological aging with a focus on human studies. Elife 2021; https://doi.org/10.7554/elife.63425
Garmany and Terzic. Healthspan-lifespan gap differs in magnitude and disease contribution across world regions. Comun Med (Lond) 2025; https://doi.org/10.1038/s43856-025-01111-2
Garmany and Terzic. Global Healthspan-Lifespan Gaps Among 183 World Health Organization Member States. JAMA Netw Open 2024; https://doi.org/10.1001/jamanetworkopen.2024.50241
Muszynska-Spielauer et al. Why do women live longer than men, but spend more time in poor health? A decomposition analysis of the gender gap in unhealthy life years across Europe. Eur J Epidemiol 2026; https://doi.org/10.1007/s10654-025-01346-2
Austad and Fischer. Sex Differences in Lifespan. Cell Metab 2016; https://doi.org/10.1016/j.cmet.2016.05.019
1,000mg
600mg
200mg
500mg
90mg
30mg
11mg
1000IU
1000mg
250mg
200mg
50mg
1000mg
200mg
1.7mg
400mcg DFE
2.4mcg
1,000mg
500mg
500mg
50mg
900mcg